MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, ISCO had -$237K decrease in cash & cash equivalents over the period. -$35K in free cash flow.

Cash Flow Overview

Change in Cash
-$237K
Free Cash flow
-$35K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Accounts receivable
    • Non-cash operating lease expense
    • Interest expense on related part...
    • Change in inventory reserve
Negative Cash Flow Breakdown
    • Inventories
    • Operating lease liabilities
    • Principal repayment on note paya...
    • Others

Cash Flow
2025-12-31
Product sales
9,100
Cost of sales
4,033
General and administrative
3,532
Selling and marketing
1,118
Research and development
684
Total operating expenses
9,367
Loss from operations
-267
Other expense, net
-151
Net loss
-418
Stock-based compensation
288
Depreciation and amortization
219
Non-cash operating lease expense
310
Interest expense on related party note payable
145
Change in inventory reserve
45
Accounts receivable
-335
Inventories
387
Prepaid expenses and other current assets
58
Accounts payable
-18
Accrued liabilities
-99
Operating lease liabilities
-354
Net cash provided by operating activities
8
Purchases of property and equipment
43
Payments for patent licenses
2
Net cash used in investing activities
-45
Principal repayment on note payable from related party
200
Net cash used in financing activities
-200
Net decrease in cash
-237
Cash, beginning of period
1,230
Cash, end of period
993
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Accounts receivable-$335K Non-cash operating leaseexpense$310K Stock-based compensation$288K Depreciation andamortization$219K Interest expense onrelated party note...$145K Change in inventoryreserve$45K Net cash provided byoperating activities$8K Canceled cashflow$1,334K Net decrease in cash-$237K Canceled cashflow$8K Net loss-$418K Inventories$387K Operating leaseliabilities-$354K Accrued liabilities-$99K Prepaid expenses andother current assets$58K Accounts payable-$18K Product sales$9,100K Net cash used infinancing activities-$200K Net cash used ininvesting activities-$45K Loss from operations-$267K Other expense, net-$151K Canceled cashflow$9,100K Principal repayment onnote payable from...$200K Purchases of property andequipment$43K Payments for patentlicenses$2K Total operatingexpenses$9,367K Cost of sales$4,033K General andadministrative$3,532K Selling and marketing$1,118K Research and development$684K

International Stem Cell CORP (ISCO)

International Stem Cell CORP (ISCO)